<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04913545</url>
  </required_header>
  <id_info>
    <org_study_id>19 September,2018 ,Version 2</org_study_id>
    <nct_id>NCT04913545</nct_id>
  </id_info>
  <brief_title>The Senstivity and Specificity of Using Salivary miRNAs in Detection of Malignant Transformation of Oral Lesions.</brief_title>
  <official_title>The Senstivity and Specificity of Using Salivary Extracellular Vesicles as Non -Invasive Source of miRNAs (412,512) in Detection of Malignant Transformation of Potientially Malignant Oral Lesions.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <brief_summary>
    <textblock>
      Due to cancer is a leading cause of death world wide , we will coduct the study to evaluate&#xD;
      the diagnostic accuracy of using salivary miRNAs (412,512) from the salivary extracellular&#xD;
      vesicles (index test) in detection of the malignant transformation of the premalignant&#xD;
      lesions using the qualitative real time polymerase chain reaction (qRT-PCR) analysis in&#xD;
      comparison to taking biopsy .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      our study is a case control study,we will coduct our study to evaluate specificity and&#xD;
      sensitivity of using salivary extracellular vesicles miRNAs (412,512) in detection of&#xD;
      malignant transformation in potientially malignant oral lesions by using qRT-PCR analysis&#xD;
      ,participants will be selected and arranged in 3 groups the control group, potentially&#xD;
      malignant group and malignant group ,the salivary samples from the participants will be&#xD;
      collected and then microRNA extraction steps will be done through the laboratory steps ,that&#xD;
      include extracellular vesicles isolation, PCR Analysis for miRNA-412 and miRNA-512 expression&#xD;
      ,also the histopathologic diagnosis and examination of all specimens were confirmed by&#xD;
      pathologist.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 5, 2019</start_date>
  <completion_date type="Actual">August 7, 2020</completion_date>
  <primary_completion_date type="Actual">January 7, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the sensitivity and specificity of salivary miRNAs (412,512) to detect the malignant transformation of oral potentially malignant lesions</measure>
    <time_frame>2 years</time_frame>
    <description>measuring the sensitivity and specificity of using the salivary miRNAs(412,512)to detect the malignant transformation in potentially malignant lesions</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">18</enrollment>
  <condition>Oral Premalignant Lesions</condition>
  <arm_group>
    <arm_group_label>normal group</arm_group_label>
    <description>participants with out any systemic medical problemes or oral lesions. we will only take saliva sample.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>potientially malignant group</arm_group_label>
    <description>participants with suspicious oral lesions without any medical diseases. we will take saliva sample and take a biopsy sample .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>malignant group</arm_group_label>
    <description>participants with already diagnosed oral malignant lesions without receiving any treatment yett</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>using salivary miRNA (412,512)</intervention_name>
    <description>quantitative real time polymerase chain reaction to detect the salivary miRNAs 412,512) to indicate the malignant transformation in potientially malignant oral lesions.</description>
    <arm_group_label>malignant group</arm_group_label>
    <arm_group_label>normal group</arm_group_label>
    <arm_group_label>potientially malignant group</arm_group_label>
    <other_name>biopsy sample for potientially maliganat and malignant group</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Group of normal control subjects: 18 Healthy subjects presenting no clinically&#xD;
             detectable oral lesions matched for age, gender, and risk factors .Group of subjects&#xD;
             with potentially malignant lesions: 18 patient with innocuous lesions.&#xD;
&#xD;
          -  Group of subjects with malignant lesions:18 patient with suspicious lesions&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinically evident lesions as morphologically altered tissue noted at conventional&#xD;
             visual tactile examination&#xD;
&#xD;
          -  Clinically evident suspicious lesions which are morphologically altered tissue noted&#xD;
             at comprehensive visual ductile examination ( CVTE) with a definitive diagnosis of a&#xD;
             potentially malignant disorders (PMD) or even a malignant disorder to be a distinct&#xD;
             possibly.&#xD;
&#xD;
          -  Healthy subjects presenting no clinically detectable oral lesions matched for age,&#xD;
             gender, and risk factors will recruited as controls.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        .&lt;18 years of age.&#xD;
&#xD;
          -  pregnant or breast feeding. .psychiatrically or mentally unstable.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ghareeb</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant lecturer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dentistry</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 29, 2021</study_first_submitted>
  <study_first_submitted_qc>May 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>June 5, 2021</last_update_submitted>
  <last_update_submitted_qc>June 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Neveen Nabil Ghareeb</investigator_full_name>
    <investigator_title>assistant lecturer in MSA university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Precancerous Conditions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

